Eli Lilly On Novo Nordisk Lawsuit, Says "We Stand Firmly Behind Our Advertising"; We Will Continue To Focus On The Science And Defend Against Novo Nordisk Lawsuit Vigorously; Rather Than Compete On The Merits Of Its Products, Novo Is Asking Court ...

Eli Lilly and Company
Novo Nordisk A/S Sponsored ADR Class B

Eli Lilly and Company

LLY

0.00

Novo Nordisk A/S Sponsored ADR Class B

NVO

0.00

- Reuters

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.